Skip to content

The pleiotropic metabolic effects of bariatric surgery.

The pleiotropic metabolic effects of bariatric surgery.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29450
Enrollment
20
Registered
2008-11-19
Start date
2009-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity insulin sensitivity bariatric surgery hypothalamus obesitas insuline gevoeligheid bariatrische chirurgie hypothalamus

Interventions

Bariatric surgery

Sponsors

Academic Medical Center (AMC), Department of Endocrinology and Metabolism P.O. Box 22660 1100 DD Amsterdam The Netherlands +31 (0)20 5669111
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 20 pre-menopausal Caucasian women scheduled for Roux-en-Y gastric bypass surgery 2. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Any chronical medical condition except for glucose intolerance, hypertension and secondary dyslipidemia 2. Use of medication which interferes with dopamine metabolism 3. Clinically overt atherosclerotic events 4. Claustrophobia and no unremovable metal objects 5. Tobacco use (i.e. smokers) 6. Malignant or uncontrolled hypertension (blood pressure >200/120 mmHg or blood pressure >180/110 mmHg with 1 or more drugs, or >160/100 with 2 or more drugs) 7. Unwilling or unable to provide informed consent

Design outcomes

Primary

MeasureTime frame
- insulin sensitivity - metabolic changes pre- post operative - metabolic differences between two subgroups - changes in hypothalamus pre- post operative - brain differences between two subgroups

Secondary

MeasureTime frame
- weight loss

Contacts

Public ContactB.A.M. Weijer, de

Academic Medical Center (AMC) Department of Endocrinology and Metabolism P.O. Box 22660 1100 DD

B.A.deWeijer@amc.uva.nl+31 (0)20 5666849

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)